Medtronic PLC (MDT)
84.51
-0.54 (-0.63%)
USD |
NYSE |
Oct 06, 13:44
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 112.33B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -30.48% |
| Valuation | |
| PE Ratio | 21.84 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 3.661 |
| Price to Book Value | 2.133 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 0.68 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.4396 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 39.88% |
News
Headline
Wire
Time (ET)
PR Newswire
10/06 05:45
PR Newswire
10/05 22:50
Globe Newswire
10/04 22:53
Globe Newswire
10/04 14:40
MT Newswires
10/04 07:10
PR Newswire
10/03 12:15
Events
| DATE | TIME | TYPE | PERIOD | REPORTED EPS |
ESTIMATED EPS |
SURPRISE | |
| 11/23/2022* | -- | Results | Q2 2023 | -- | 1.28 | -- | |
| 11/23/2022* | 07:00 EST | Earnings Call | Q2 2023 | -- | -- | -- | |
| 08/23/2022 | -- | Results | Q1 2023 | 1.13 | 1.12 | 1.02% | |
| 08/23/2022 | 08:00 EST | Earnings Call | Q1 2023 | -- | -- | -- | |
| 05/26/2022 | -- | Results | Q4 2022 | 1.52 | 1.56 | -2.82% | |
| 05/26/2022 | 08:00 EST | Earnings Call | Q4 2022 | -- | -- | -- | |
| 02/22/2022 | -- | Results | Q3 2022 | 1.37 | 1.37 | 0.20% | |
| 02/22/2022 | 08:00 EST | Earnings Call | Q3 2022 | -- | -- | -- |
*Estimated Date/Time
Earnings
Profile
Edit
| One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales. |
| URL | https://www.medtronic.com |
| Investor Relations URL | https://investorrelations.medtronic.com |
| HQ State/Province | N/A |
| Sector | Healthcare |
| Industry | Medical Devices |
| Equity Style | Large Cap/Blend |
| Next Earnings Release | Nov. 23, 2022 (est.) |
| Last Earnings Release | Aug. 23, 2022 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Sep. 22, 2022 |
Analyst Coverage
|
Consensus Rating
|
|
|
Analyst Recommendation
|
|
Source: S&P Global
Dividends
| Dividend Per Share (TTM) | 2.57 |
|
2017
2018
2019
2020
2021
6.00%
4.00%
2.00%
|
|
| Yield to Market | 2.097 |
| Yield to Sector | 1.669 |
| Yield to Industry | 1.732 |
| Last Dividend Amt. | 0.68 |
| Dividend Frequency | Quarterly |
| Last Ex-Dividend Date | Sep. 22, 2022 |
| Yield (TTM) | 3.10% |
| Forward Yield | 3.20% |
| Payout Ratio | 66.09% |
| Cash Payout Ratio | 60.13% |
| Consistent Payer (5Y) |
|
| Consistent Growth (5Y) |
|
Risk Info
Total Returns Comparison
Annual Total Returns Versus Peers
As of October 05, 2022.
Fundamentals
| Revenue (TTM) | 31.07B |
| Total Expenses (TTM) | 24.92B |
| Net Income (TTM) | 5.205B |
| Total Assets (Quarterly) | 89.91B |
| Total Liabilities (Quarterly) | 37.07B |
| Shareholders Equity (Quarterly) | 52.67B |
| Cash from Operations (TTM) | 7.137B |
| Cash from Investing (TTM) | -2.46B |
| Cash from Financing (TTM) | -5.231B |
Ratings
Profile
Edit
| One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales. |
| URL | https://www.medtronic.com |
| Investor Relations URL | https://investorrelations.medtronic.com |
| HQ State/Province | N/A |
| Sector | Healthcare |
| Industry | Medical Devices |
| Equity Style | Large Cap/Blend |
| Next Earnings Release | Nov. 23, 2022 (est.) |
| Last Earnings Release | Aug. 23, 2022 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Sep. 22, 2022 |
Risk Info
Ownership
| Insider Ownership Percentage | Upgrade |
Jul '20
Nov '20
Mar '21
80.00%
40.00%
10.00%
Analyst Coverage
|
Consensus Rating
|
|
|
Analyst Recommendation
|
|
Source: S&P Global
Top Fund Holders
| Symbol | Dollars Invested | % Weight |
|---|---|---|
| IHI | 560.91M USD | 9.54% |
| AEIMX | 451.95M USD | 4.38% |
| MOAT | 152.32M USD | 2.43% |
| XLV | 881.66M USD | 2.36% |
| VDIGX | 1.138B USD | 2.26% |
| HDV | 257.98M USD | 2.23% |
| VHCIX | 397.23M USD | 2.14% |
| VHT | 397.23M USD | 2.14% |
| VWNFX | 1.054B USD | 2.12% |
| MSDVX | 438.72M USD | 2.01% |
| FRDRX | 474.03M USD | 1.95% |
| DGRO | 230.41M USD | 1.07% |
Other Resources
| Whale Wisdom | 13F Filings |
| Seeking Alpha | Call Transcripts |
| Morningstar | Insider Trading |
| Nasdaq | Institutional Ownership |
| Nasdaq | Option Chain |
| SEC | SEC Filings |
| MDT Tweets |